Relmada Therapeutics Inc (NASDAQ: RLMD)
Investors finally get a glimpse of Relmada Therapeutics Inc (RLMD) volume hitting the figure of 0.64 million.
On Friday, Relmada Therapeutics Inc (NASDAQ: RLMD) was 6.00% up from the session before settling in for the closing price ...
Let’s look at the key reasons that are pushing Relmada Therapeutics Inc (RLMD) to new highs
A new trading day began on Tuesday, with Relmada Therapeutics Inc (NASDAQ: RLMD) stock price down -8.60% from the previous ...
A look at Relmada Therapeutics Inc’s (RLMD) recent performance gives investors their first glimpse of hope.
Relmada Therapeutics Inc (NASDAQ: RLMD) on Tuesday, soared 7.56% from the previous trading day, before settling in for the closing ...
Relmada Therapeutics Inc (RLMD) with a beta value of 0.79 appears to be a promising investment opportunity.
On Monday, Relmada Therapeutics Inc (NASDAQ: RLMD) opened higher 13.58% from the last session, before settling in for the closing ...
10.97% volatility in Relmada Therapeutics Inc (RLMD) last month: This is a red flag warning
A new trading day began on Tuesday, with Relmada Therapeutics Inc (NASDAQ: RLMD) stock price up 25.91% from the previous ...
Relmada Therapeutics Inc (RLMD) with a beta value of 0.85 appears to be a promising investment opportunity.
Relmada Therapeutics Inc (NASDAQ: RLMD) kicked off on Monday, down -10.34% from the previous trading day, before settling in for ...
Relmada Therapeutics Inc (RLMD) volume hits 0.92 million: A New Opening for Investors
Relmada Therapeutics Inc (NASDAQ: RLMD) established initial surge of 23.15% at $2.66, as the Stock market unbolted on Thursday, before ...
